Company overview
BioChromato specializes in Smart Evaporator systems that enable 5x faster solvent evaporation without bumping, using vacuum-assisted vortex concentration (VVC) technology ideal for removing difficult solvents like DMSO, DMF, and water in pharmaceutical R&D. Models like the C10 process up to 10 samples simultaneously, while fully automatic versions handle up to 140 samples across multiple container types. These tools enhance lab efficiency, safety, and compatibility with small to medium volumes (1-50 mL) for life sciences applications.
Biochromato is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include smart evaporator, bump-free evaporation, dmso evaporation, pharma lab equipment, solvent concentration.
Products and technologies associated with Biochromato include Equipment — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://biochromato.com
- Markets served
- United States & Americas
- Keywords
- smart evaporator, bump-free evaporation, dmso evaporation, pharma lab equipment, solvent concentration
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What evaporation technology does BioChromato use?
- BioChromato employs vacuum-assisted vortex concentration (VVC) with spiral plug design for bump-free evaporation, delivering 5x faster rates and 2.4x volatility boost via RAPID Slit Seal, effective for DMSO, DMF, and water.
- What are the sample processing capabilities?
- Smart Evaporator C10 handles 10 samples at once; fully automatic models process up to 140 samples continuously, supporting four container types simultaneously for small to medium volumes (1-50 mL).
- What applications suit BioChromato evaporators in pharma?
- Ideal for pharmaceutical R&D solvent removal, large-scale processing, precise temperature control, and versatile lab workflows, complementing rotary evaporators while eliminating bumping risks without specialized equipment.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
